Nuvaring®
Manufacturer: Organon USA, Inc.,
Uses: Contraception (Birth control)
NuvaRing ® is a contraceptive vaginal ring that was approved by the Food and Drug Administration in 2001. Since that time, this contraceptive device has been the subject of more than 100 lawsuits stemming from claims of adverse reactions and side effects.
If you or a loved one believe you have been harmed as a result of using NuvaRing ® , contact the pharmaceutical litigation attorneys at Peterson & Associates today. Call 1-877-378-4442 for a free claim review or contact us online .
NuvaRing® is inserted into the vagina for three weeks and then removed for one week to allow menstruation. A new ring is then inserted and the cycle is repeated.
Like other forms of birth control, NuvaRing® works by releasing two hormones, estrogen and progestin, into the body. NuvaRing® uses a progestin called Etonogestrel, the active metabolite of a third-generation hormone called desogestrel. In 2007, the consumer safety group Public Citizen petitioned the FDA to ban the use of third-generation oral contraceptives -- contraceptives taken in pill form -- due to an increased risk of dangerous blood clots. Blood clots can travel through the body's circulatory system and cause severe damage to the brain, heart and lungs, including heart attack and stroke.
In fact, all hormone-based contraceptives increase a woman's chance of developing blood clots, which can lead to strokes. The manufacturer of NuvaRing® notes that the ring contains a lower hormone dose than most oral contraceptives and points to a study that concluded switching from the pill to the ring appeared to lower the chance of clotting.
The most common adverse events reported by five to 14 percent of women using NuvaRing® in clinical trials were vaginitis, headache, upper respiratory tract infection, vaginal secretion, sinusitis, weight gain and nausea. The manufacturer acknowledges that an increased risk of the following serious adverse reactions has been associated with the use of combination hormonal contraceptives:
- Thrombophlebitis and venous thrombosis with or without embolism;
- Cerebral hemorrhage;
- Cerebral thrombosis;
- Hypertension;
- Arterial thromboembolism;
- Gallbladder disease;
- Pulmonary embolism;
- Hepatic adenomas or benign liver tumors;
- Myocardial infarction;
- Loss of scalp hair.
If you or a loved one has been injured as a result of using NuvaRing®, you may be entitled to compensation for your medical bills, loss of income and pain and suffering. But building a successful claim against a pharmaceutical company can be very challenging. You will need an attorney with a proven record of success in pharmaceutical litigation. The pharmaceutical attorneys at Peterson & Associates can help you understand your legal rights. Call 1-877-378-4442 today for a free claim review or contact us online .
For more information:
Pharmaceutical Litigation
Prescription
Injury FAQs
Pharmaceutical Legal Glossary
|
